Today: 11 June 2026
Intel stock slides 5% as board chair exit lands after the bell; traders eye next Intel update
3 March 2026
2 mins read

Intel stock slides 5% as board chair exit lands after the bell; traders eye next Intel update

NEW YORK, March 3, 2026, 4:56 PM ET — After-hours trade

  • Intel dropped roughly 5% during the session, and shares barely budged in after-hours action.
  • Intel announced that board chair Frank Yeary plans to step down following the annual meeting in May, with Craig Barratt set to take over the role.
  • Oil surged with the Middle East conflict intensifying, weighing on both tech and broader stocks.

Intel dropped 5.3% to $43.08 on Tuesday, with shares holding steady after hours, following news that board chair Frank Yeary plans to step down after the company’s annual meeting in May.

This drop has real weight; markets are acting as if “war-and-inflation” mode is back on the table. Spiking oil prices have investors rethinking just how fast the Federal Reserve might move to cut rates, which usually puts immediate pressure on rate-sensitive tech and chip stocks. Reuters

Intel’s turnaround remains underway, with investors closely watching everything from execution to factory performance and how quickly new chips hit the market. The board has already seen a series of changes in the last year, and Yeary’s departure marks yet another move.

Intel’s board has tapped Craig H. Barratt to serve as independent chair, the company announced. Barratt will step into the role following the May 13 annual meeting. A member of Intel’s board since 2025, Barratt earlier headed up Atheros Communications before taking the reins at Qualcomm Atheros.

According to the company’s statement, chief executive Lip-Bu Tan credited Yeary with having “led the effort to bring me in” and noted that Intel has taken “decisive actions to strengthen our financial foundation.” Yeary, for his part, called this “the appropriate time” to step aside, framing the move as Intel continues what he described as a “multi-year effort.” Intel Corporation

Stocks got hit across the board. Both the S&P 500 and Nasdaq finished in the red, with the S&P slipping under its 100-day moving average — a level traders have been eyeing — for the first time since November, according to Reuters.

Jed Ellerbroek, portfolio manager over at Argent Capital Management, told Reuters the Iran conflict has triggered “a lot of emergency meetings” and turned client conversations “skittish” and a lot more “serious.” Reuters

Intel’s slide today underscored just how little slack there is for surprises tied to the company itself—especially with bigger macro stories setting the tone. If crude oil keeps pushing higher and volatility holds up, any late-in-the-day board news can end up buried.

Still, one session doesn’t tell the whole story. Intel’s seen some wild moves lately. Swapping out top executives won’t magically solve issues like lagging products, rivals closing in, or the company’s own manufacturing stumbles—the real drivers behind earnings shifts.

Investors now turn to something specific and soon: Intel will be presenting at the Morgan Stanley Technology, Media & Telecom Conference on March 4, as listed on its investor relations calendar. After that, eyes shift to the May 13 annual meeting—when the board chair transition is supposed to happen.

Stock Market Today

  • Wall Street Gains on AI Stock Rally Amid Inflation and Middle East Tensions
    June 11, 2026, 11:16 AM EDT. Wall Street recovered some weekly losses Thursday as artificial intelligence (AI) stocks rebounded, led by chipmakers like Marvell Technology (+5.5%), Intel (+7.8%), and Applied Materials (+7.5%). The S&P 500 rose 0.5%, Dow Jones 0.7%, and Nasdaq 0.7%. Despite market gains, concerns about elevated AI valuations persist, while Oracle shares fell 11.1% after revealing plans to raise $40 billion to fund AI investments. Oil prices remained steady despite rising tensions in the Iran conflict, with Brent crude at $92.64 and U.S. crude at $90.29 per barrel. Meanwhile, wholesale inflation in the U.S. exceeded expectations in May, prompting the European Central Bank to raise interest rates, signaling global inflationary pressures.

Latest articles

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

11 June 2026
TOVX soared 74.6% to $0.4252 after Theriva Biologics published Phase 1 VCN-01 data showing survival and biomarker signals in head-and-neck cancer, but the jump was not due to drug approval or revenue; investors face ongoing financing, dilution, and clinical-trial execution risks, with the company’s cash runway only into Q1 2027 and substantial doubt about its ability to continue as a going concern without new capital.
Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

11 June 2026
Trulieve began NYSE trading as TRLV this week after moving from OTC/CSE, authorized a buyback of up to $50 million or 8.5 million shares, and closed its first NYSE session at $11.50, down 0.43%, before trading near $11.78 early Thursday, as investors weigh whether the uplisting and buyback will boost demand amid ongoing federal cannabis policy uncertainty.
Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

11 June 2026
Propanc Biopharma shares soared as much as 392% after authorizing up to $5 million in stock buybacks—exceeding its prior $3.1 million equity value—even as it reported just $443,702 in cash and flagged going-concern risks, with investors now focused on whether its lead cancer drug PRP will advance to a planned Phase 1b trial this year.
Amazon stock slides after AWS drone strikes hit Middle East data centers — what’s next for AMZN
Previous Story

Amazon stock slides after AWS drone strikes hit Middle East data centers — what’s next for AMZN

CrowdStrike stock holds steady after upbeat 2027 forecast as Wall Street sizes up ARR
Next Story

CrowdStrike stock holds steady after upbeat 2027 forecast as Wall Street sizes up ARR

Go toTop